193
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Albumin Corrected Anion Gap and the Risk of in-Hospital Mortality in Patients with Acute Pancreatitis: A Retrospective Cohort Study

, , , , ORCID Icon, & show all
Pages 2415-2422 | Received 11 Apr 2023, Accepted 02 Jun 2023, Published online: 07 Jun 2023
 

Abstract

Purpose

To explore the prognostic value of albumin corrected anion gap (ACAG) within 24 hours of admission to the intensive care unit (ICU) for acute pancreatitis (AP).

Patients and Methods

This was a retrospective cohort study. Adult AP patients admitted to ICU from June 2016 to December 2019 were included in the study, who were divided into three groups according to initial serum ACAG within 24 hours upon ICU admission: ACAG ≤ 14.87 mmol/L, 14.87 < ACAG ≤ 19.03 mmol/L, and ACAG > 19.03 mmol/L. The primary study outcome indicator was in-hospital mortality. Age, sex, Glasgow Coma Scale score, and Acute Physiology and Chronic Health Evaluation II (APACHE II) score were matched through propensity score matching (PSM) method to balance the baseline between the survivors and non-survivors. Multivariate Cox regression was used to determine the relationship between ACAG and in-hospital mortality.

Results

A total of 344 patients (of them 81 non-survivors) were analyzed in this study. Patients with higher ACAG intended to present significantly higher in-hospital mortality, APACHE II score, creatine, lower albumin, and bicarbonate. Multivariate Cox regression analysis after matching demonstrated that white blood cell count, platelet count, and higher ACAG were independently associated with higher in-hospital mortality (ACAG ≤ 14.87 as a reference, 14.87 < ACAG ≤ 19.03 mmol/L with HR of 2.34 and 95% CI of 1.15–4.76, ACAG >19.03 with HR of 3.46 and 95% CI of 1.75–6.84).

Conclusion

Higher ACAG was independently associated with higher in-hospital mortality in patients with AP after matching the baseline between the survivors and non-survivors.

Ethics Approval and Informed Consent

This study was approved by the biomedical ethics committee of West China Hospital of Sichuan University, and the approval ID was 2021 (1694).

Consent for Publication

We have confirmed that the details included in this study can be published.

Acknowledgments

We would like to thank all the volunteers who took part in this study and all the participants for their contribution to data collection and analysis.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors declare that they have no competing interests, and confirm that there are no financial or personal relationships with other people or organizations.

Additional information

Funding

This work was supported by Project funded by China Postdoctoral Science Foundation (2021M692298).